The goal of this observational study is to compare pulmonary health parameter measurements from the VQm PHM™ to existing clinical measurements. The main questions it aims to answer are: * Confirm the performance of non-invasive pulmonary health parameter shunt fraction value found on the VQm PHM™ when compared to available reference measurements. * Confirm the performance of non-invasive pulmonary health parameter pulmonary blood flow, functional residual capacity and physiological dead space found on the VQm PHM™ when compared to available reference measurements.
This is a multi-site, international, prospective, non-blinded, non-randomized, observational study. This study aims to compare measurements from the VQm PHM™ to existing clinical measurements, assess safety of the device and determine effects that standard clinical events have on the VQm PHM™ measurements. This study does not include changes to clinical care based on measurements from the VQm PHM™. Each patient will serve as their own control.
Study Type
OBSERVATIONAL
Enrollment
150
The VQm Pulmonary Health Monitor™ (may be referred to as the VQm PHM™) is a a Class IIa, Health Canada approved medical device used as an adjunct monitor and is non-life supporting, providing clinicians with measurements of pulmonary function parameters of mechanically ventilated adult patients. The measurements provided are: * Pulmonary Blood Flow (PBF) * Shunt Fraction (Qsi) * Dead space (VD): * Functional Residual Capacity (FRC)
UC Davis Medical Center
Sacramento, California, United States
Medical University of Vienna
Vienna, Austria
University Hospital Kralovske Vinohrady
Prague, Czechia
Hôpital Européen Georges Pompidou
Paris, France
Shunt fraction value
Confirming the performance of non-invasive pulmonary health parameter shunt value found on the VQm PHM™ monitor when compared to available reference measurements
Time frame: Through study completion, an average of 12 months
Pulmonary blood flow - trend
Confirming the performance of non-invasive pulmonary health parameter PBF trend found on the VQm PHM™ monitor when compared to available reference measurements
Time frame: Through study completion, an average of 12 months
Functional residual capacity - trend
Confirming the performance of non-invasive pulmonary health parameter FRC trend found on the VQm PHM™ monitor when compared to available reference measurements
Time frame: Through study completion, an average of 12 months
Pulmonary blood flow - absolute value
Confirming the performance of non-invasive pulmonary health parameter PBF absolute values found on the VQm PHM™ monitor when compared to available reference measurements
Time frame: Through study completion, an average of 12 months
Functional residual capacity - absolute value
Confirming the performance of non-invasive pulmonary health parameter FRC absolute values found on the VQm PHM™ monitor when compared to available reference measurements
Time frame: Through study completion, an average of 12 months
Physiological dead space
Confirming the performance of non-invasive pulmonary health parameter physiological dead space value found on the VQm PHM™ monitor when compared to available reference measurements
Time frame: Through study completion, an average of 12 months
Oxygen desaturation due to breathing circuit connectivity (safety)
Number of participants with treatment-related adverse events due to faulty connecting the breathing circuit during normal operation the VQm PHM™ monitor as measured by oxygen saturation desaturations of SpO2 \<89% for \>14s.
Time frame: Through completion of study, up to 72 horus
High pressure due to volume control (safety)
Number of participants with device-related adverse events due to increased pressure induced by volume-control mode as determined by peak pressure \>10cm H2O ventilator setting.
Time frame: Through completion of study, up to 72 hours
High volume due to pressure control (safety)
Number of participants with device-related adverse events due to increased volume induced by pressure-control mode as determined by a volume \>200mL from target volume.
Time frame: Through completion of study, up to 72 hours
Safe range of nitrous oxide delivery (safety)
Confirming the acceptable safety limitations of nitrous oxide gas delivery by the VQm PHM™ monitor below 10% as measured by the device.
Time frame: Through completion of study, up to 72 hours
Incident rate of adverse events, adverse events and treatment-emergent serious adverse events
As deemed caused by the the VQm PHM™ monitor during standard of care in the ICU setting.
Time frame: Through completion of study, up to 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.